Skip to main content
Clinical Trials/JPRN-jRCT1052230161
JPRN-jRCT1052230161Active, not recruitingPhase 3

Validation of Pathophysiology in Heart Failure Exacervation using echo Vector Flow Mapping

Kawaji Testuma0 sites400 target enrollmentStarted: January 9, 2024Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Active, not recruiting
Sponsor
Enrollment
400

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
>= 20age old to <= 90age old (—)
Sex
All

Inclusion Criteria

  • •patients who receive transthoracic echocardiography in our hospital
  • •patints who can be followed for at least 1 year

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Kawaji Testuma

Similar Trials